Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04890314 · ClinicalTrials.gov registry record
Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 1,953
- Enrollment target
NCT04890314 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 1,953 participants.
The verdict
NCT04890314 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 1,953 participants
- Enrollment target
Study Summary
This study will use a population-based cohort design to study men with newly diagnosed low- and intermediate-risk prostate cancer at high-volume centers in Southern California (SCa) and New York State (NYS). Complications of contemporary treatments for prostate cancer and quality of life outcomes, such as general health, urinary, sexual, and bowel function, cancer anxiety, and treatment regret will be compared and tracked over the course of this study.
Interventions
- OTHER Patient-reported questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,953 participants |
| Start Date | 2021-05-15 |
| Est. Completion | 2024-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04890314
The ClinicalTrials.gov registry entry for NCT04890314 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,953 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patient-reported questionnaire is the first listed.
NCT04890314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04890314 about?
NCT04890314 is a clinical study titled "Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment". This study will use a population-based cohort design to study men with newly diagnosed low- and intermediate-risk prostate cancer at high-volume centers in Southern California (SCa) and New York State (NYS). Complications of contemporary treatments for prostate cancer and quality of life outcomes, s...
What is the current status of trial NCT04890314?
This trial is currently completed. The enrollment target is 1,953 participants. The study started on 2021-05-15. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT04890314?
The interventions under investigation include: Patient-reported questionnaire (OTHER).
Who is sponsoring clinical trial NCT04890314?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.